nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—cleft lip	0.0866	0.0866	CbGpPWpGaD
Epoprostenol—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—TCN2—cleft lip	0.0718	0.0718	CbGpPWpGaD
Epoprostenol—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—MTR—cleft lip	0.0498	0.0498	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—BMP4—cleft lip	0.0361	0.0361	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—TGFB3—cleft lip	0.0336	0.0336	CbGpPWpGaD
Epoprostenol—PTGIR—Endothelin Pathways—NOS3—cleft lip	0.0295	0.0295	CbGpPWpGaD
Epoprostenol—PTGIS—Biological oxidations—MTR—cleft lip	0.0288	0.0288	CbGpPWpGaD
Epoprostenol—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cleft lip	0.0266	0.0266	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—WNT9B—cleft lip	0.0231	0.0231	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—WNT9B—cleft lip	0.0213	0.0213	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—WNT9B—cleft lip	0.0213	0.0213	CbGpPWpGaD
Epoprostenol—PTGIR—Thromboxane A2 receptor signaling—NOS3—cleft lip	0.0194	0.0194	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—WNT3—cleft lip	0.0184	0.0184	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TGFB3—cleft lip	0.0173	0.0173	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—WNT3—cleft lip	0.0169	0.0169	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—WNT3—cleft lip	0.0169	0.0169	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TGFB3—cleft lip	0.0159	0.0159	CbGpPWpGaD
Epoprostenol—PTGIR—Platelet homeostasis—NOS3—cleft lip	0.0148	0.0148	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ARHGAP29—cleft lip	0.0128	0.0128	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—WNT9B—cleft lip	0.0126	0.0126	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—WNT9B—cleft lip	0.0119	0.0119	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ARHGAP29—cleft lip	0.0118	0.0118	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ARHGAP29—cleft lip	0.0118	0.0118	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—ABCA4—cleft lip	0.0112	0.0112	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—WNT9B—cleft lip	0.0109	0.0109	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—WNT9B—cleft lip	0.0109	0.0109	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SLC19A1—cleft lip	0.0103	0.0103	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—PTCH1—cleft lip	0.0101	0.0101	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—WNT3—cleft lip	0.01	0.01	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—WNT3—cleft lip	0.00942	0.00942	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—PTCH1—cleft lip	0.00926	0.00926	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—PTCH1—cleft lip	0.00926	0.00926	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—WNT3—cleft lip	0.00867	0.00867	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—WNT3—cleft lip	0.00867	0.00867	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—SLC19A1—cleft lip	0.00859	0.00859	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TCN2—cleft lip	0.0085	0.0085	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—TCN2—cleft lip	0.00712	0.00712	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—WNT9B—cleft lip	0.00701	0.00701	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOG—cleft lip	0.00672	0.00672	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGF7—cleft lip	0.00661	0.00661	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SPRY2—cleft lip	0.00661	0.00661	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—WNT9B—cleft lip	0.00645	0.00645	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—WNT9B—cleft lip	0.00645	0.00645	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ABCA4—cleft lip	0.00625	0.00625	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOG—cleft lip	0.00618	0.00618	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOG—cleft lip	0.00618	0.00618	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGF8—cleft lip	0.0061	0.0061	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MTR—cleft lip	0.00589	0.00589	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ABCA4—cleft lip	0.00575	0.00575	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ABCA4—cleft lip	0.00575	0.00575	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—WNT3—cleft lip	0.00557	0.00557	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PTCH1—cleft lip	0.00516	0.00516	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—WNT3—cleft lip	0.00512	0.00512	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—WNT3—cleft lip	0.00512	0.00512	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGF3—cleft lip	0.00497	0.00497	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—MTR—cleft lip	0.00493	0.00493	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGF9—cleft lip	0.00484	0.00484	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PTCH1—cleft lip	0.00475	0.00475	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PTCH1—cleft lip	0.00475	0.00475	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—MTR—cleft lip	0.00466	0.00466	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGF10—cleft lip	0.00408	0.00408	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF7—cleft lip	0.00368	0.00368	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SPRY2—cleft lip	0.00368	0.00368	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—NOS3—cleft lip	0.00361	0.00361	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF8—cleft lip	0.0034	0.0034	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SPRY2—cleft lip	0.00339	0.00339	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SPRY2—cleft lip	0.00339	0.00339	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF7—cleft lip	0.00339	0.00339	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF7—cleft lip	0.00339	0.00339	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—NOS3—cleft lip	0.00333	0.00333	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGFR2—cleft lip	0.00328	0.00328	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MTHFR—cleft lip	0.00315	0.00315	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF8—cleft lip	0.00313	0.00313	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF8—cleft lip	0.00313	0.00313	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGFR1—cleft lip	0.00305	0.00305	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTCH1—cleft lip	0.00305	0.00305	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—TYMS—cleft lip	0.00302	0.00302	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGFR3—cleft lip	0.00289	0.00289	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTCH1—cleft lip	0.00281	0.00281	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTCH1—cleft lip	0.00281	0.00281	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF3—cleft lip	0.00277	0.00277	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF9—cleft lip	0.0027	0.0027	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—MTHFR—cleft lip	0.00264	0.00264	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF3—cleft lip	0.00254	0.00254	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF3—cleft lip	0.00254	0.00254	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF9—cleft lip	0.00248	0.00248	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF9—cleft lip	0.00248	0.00248	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF10—cleft lip	0.00227	0.00227	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—FGF2—cleft lip	0.00223	0.00223	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS3—cleft lip	0.0022	0.0022	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF10—cleft lip	0.00209	0.00209	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF10—cleft lip	0.00209	0.00209	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—NOS3—cleft lip	0.00184	0.00184	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGFR2—cleft lip	0.00182	0.00182	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGFR1—cleft lip	0.0017	0.0017	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGFR2—cleft lip	0.00168	0.00168	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGFR2—cleft lip	0.00168	0.00168	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGFR3—cleft lip	0.00161	0.00161	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGFR1—cleft lip	0.00157	0.00157	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGFR1—cleft lip	0.00157	0.00157	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGFR3—cleft lip	0.00148	0.00148	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGFR3—cleft lip	0.00148	0.00148	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MYC—cleft lip	0.00146	0.00146	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC19A1—cleft lip	0.00139	0.00139	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FGF2—cleft lip	0.00124	0.00124	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOS3—cleft lip	0.00123	0.00123	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TCN2—cleft lip	0.00115	0.00115	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FGF2—cleft lip	0.00114	0.00114	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FGF2—cleft lip	0.00114	0.00114	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOS3—cleft lip	0.00113	0.00113	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOS3—cleft lip	0.00113	0.00113	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MYC—cleft lip	0.000812	0.000812	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MTR—cleft lip	0.000797	0.000797	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MYC—cleft lip	0.000747	0.000747	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MYC—cleft lip	0.000747	0.000747	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TYMS—cleft lip	0.000489	0.000489	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MTHFR—cleft lip	0.000427	0.000427	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NOS3—cleft lip	0.000298	0.000298	CbGpPWpGaD
